Fluoxetina Genfar may be available in the countries listed below.
Fluoxetine is reported as an ingredient of Fluoxetina Genfar in the following countries:
Fluoxetine hydrochloride (a derivative of Fluoxetine) is reported as an ingredient of Fluoxetina Genfar in the following countries:
International Drug Name Search
Relieva may be available in the countries listed below.
Frovatriptan succinate monohydrate (a derivative of Frovatriptan) is reported as an ingredient of Relieva in the following countries:
International Drug Name Search
Flupamid may be available in the countries listed below.
Indapamide is reported as an ingredient of Flupamid in the following countries:
International Drug Name Search
Ledclair may be available in the countries listed below.
Edetic Acid calcium disodium salt (a derivative of Edetic Acid) is reported as an ingredient of Ledclair in the following countries:
International Drug Name Search
Reodon may be available in the countries listed below.
Repaglinide is reported as an ingredient of Reodon in the following countries:
International Drug Name Search
Diclofenac-Akri may be available in the countries listed below.
Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Diclofenac-Akri in the following countries:
International Drug Name Search
Controlling symptoms of ulcerative colitis in patients who cannot take sulfasalazine.
Olsalazine is a salicylate. It works by reducing inflammation of the colon by possibly preventing the production of substances that cause this inflammation.
Contact your doctor or health care provider right away if any of these apply to you.
Some medical conditions may interact with Olsalazine. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some MEDICINES MAY INTERACT with Olsalazine. Tell your health care provider if you are taking any other medicines, especially any of the following:
This may not be a complete list of all interactions that may occur. Ask your health care provider if Olsalazine may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Use Olsalazine as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Ask your health care provider any questions you may have about how to use Olsalazine.
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Diarrhea; joint pain; nausea; stomach pain or cramps.
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); change in the amount of urine; chest pain; dark urine; fast or irregular heartbeat; pale stools; severe stomach pain; trouble urinating; unusual bruising or bleeding; yellowing of the eyes or skin.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
See also: Olsalazine side effects (in more detail)
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include nausea, vomiting, or diarrhea.
Store Olsalazine in a tightly closed container at room temperature, between 68 and 77 degrees F (20 and 25 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Olsalazine out of the reach of children and away from pets.
This information is a summary only. It does not contain all information about Olsalazine. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.
Sample Packaging:
| RENATE Renate DHA prenatal multivitamin and minerals with dha tablet | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Marketing Information | |||
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| unapproved drug other | 01/02/2009 | 12/31/2010 | |
| Labeler - River's Edge Pharmaceuticals, LLC (133879135) |
Generic Name: digoxin immune FAB (di JOX in im MYOON FAB)
Brand Names: Digibind, DigiFab
Digoxin immune FAB is used as an antidote to treat a life-threatening overdose of digoxin or digitoxin.
Digoxin immune FAB is not for treating a mild digitalis overdose.
Digoxin immune FAB may also be used for other purposes not listed in this medication guide.
In an emergency situation, it may not be possible before you are treated to tell your caregivers about any health conditions you have or if you are pregnant or breast-feeding. However, make sure any doctor caring for you afterward knows that you received this medication.
After treatment with digoxin immune FAB, you will be watched to make sure the medication has been effective and you no longer have any effects of the digitalis overdose.
heart disease;
kidney disease;
if you are allergic to antibiotics; or
if you are allergic to papaya extracts such as papain or chymopapain (Chymodiactin).
In a poisoning situation, it may not be possible to tell your caregivers that you are pregnant or breast-feeding before you are treated with digoxin immune FAB. However, make sure any doctor caring for your pregnancy or your baby knows that you have received the medication.
Digoxin immune FAB is given as an injection through a needle placed into a vein. You will receive this injection in a hospital or emergency setting. The medicine must be given slowly through an IV infusion, and each dose can take up to 30 minutes to complete.
To be sure this medication is helping your condition and not causing harmful side effects, your blood will need to be tested on a regular basis. This will help your doctor determine how long to treat you with digoxin immune FAB.
This medication can cause you to have unusual results with certain digitalis tests. Tell any doctor who treats you that you have been treated with digoxin immune FAB.
Since digoxin immune FAB is given in an emergency situation by a healthcare professional, it is not likely that you will miss a dose.
An overdose of this medication is unlikely since it is given by a healthcare provider.
Follow your doctor's instructions about any restrictions on food, beverages, or activity after you are treated with digoxin immune FAB.
fever;
high potassium (slow heart rate, weak pulse, muscle weakness, tingly feeling);
low potassium (confusion, uneven heart rate, extreme thirst, increased urination, leg discomfort, muscle weakness or limp feeling);
feeling short of breath, even with mild exertion; or
swelling, rapid weight gain.
This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.
Usual Adult Dose for Digitalis Glycoside Toxicity:
Unknown amount of ingestion: 800 mg IV infusion if acute ingestion, 240 mg IV infusion if chronic ingestion.
Dosing for Ingestion of a Single Large Dose:
Dose (in # of vials) = (Total digitalis body load in mg) / (0.5 mg of digitalis bound per vial).
Total digitalis body load in mg = (number of tablets/capsules ingested) x (mg strength of the tablet/capsule) x (bioavailability of tablet/capsule). Digoxin tablets and elixir are 80% bioavailable, digoxin capsules and injection are 100% bioavailable.
Dosing based on Serum Level:
Digoxin: Dose (in # of vials) = (Serum digoxin level in ng/mL) x (weight in kg) / (100).
Digitoxin: Dose (in # of vials) = (Serum digitoxin level in ng/mL) x (weight in kg) / (1000).
Digoxin immune Fab should be administered intravenously once over at least 30 minutes or, in the case of imminent cardiac arrest, as a bolus injection.
The above dosing scenarios are based on the following: each vial contains 40 mg of immune Fab; each vial will bind approximately 0.5 mg of cardiac glycoside.
Usual Pediatric Dose for Digitalis Glycoside Toxicity:
Dosing for Ingestion of a Single Large Dose:
Dose (in # of vials) = (Total digitalis body load in mg) / (0.5 mg of digitalis bound per vial).
Total digitalis body load in mg = (number of tablets/capsules ingested) x (mg strength of the tablet/capsule) x (bioavailability of tablet/capsule). Digoxin tablets and elixir are 80% bioavailable, digoxin capsules and injection are 100% bioavailable.
Children less than or equal to 20 kg: Dilution of reconstituted vial to 1 mg/mL may be desirable for doses of 3 mg or less.
Dose ( in # of mg) = Dose (in # vials) x 38 mg/vial.
Dose (in # of vials) = (Serum digoxin level in ng/mL) x (weight in kg) / (100).
Digoxin immune Fab should be administered intravenously once over at least 30 minutes or, in the case of imminent cardiac arrest, as a bolus injection. The vial may be reconstituted and administered undiluted using a tuberculin syringe in infants and small children requiring small doses.
The above dosing scenarios are based on the following: each vial contains 40 mg of immune Fab; each vial will bind approximately 0.5 mg of cardiac glycoside.
This list is not complete and there may be other drugs that can interact with digoxin immune FAB. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.
See also: digoxin immune FAB side effects (in more detail)
